Is Mitochondrial Oxidative Stress a Viable Therapeutic Target in Preeclampsia?
Despite considerable research efforts over the past few decades, the pathology of preeclampsia (PE) remains poorly understood with no new FDA-approved treatments. There is a substantial amount of work being conducted by investigators around the world to identify targets to develop therapies for PE....
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2022-01-01
|
| Series: | Antioxidants |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/2076-3921/11/2/210 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|